↓ Skip to main content

Cochrane Database of Systematic Reviews

Thalidomide for managing cancer cachexia

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
254 Mendeley
Title
Thalidomide for managing cancer cachexia
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd008664.pub2
Pubmed ID
Authors

Joanne Reid, Moyra Mills, Marie M Cantwell, Chris R Cardwell, Liam J Murray, Michael Donnelly

Abstract

Cancer cachexia is a multidimensional syndrome characterised by wasting, loss of weight, loss of appetite, metabolic alterations, fatigue and reduced performance status. A significant number of patients with advanced cancer develop cachexia before death. There is no identified optimum treatment for cancer cachexia. While the exact mechanism of the action of thalidomide is unclear, it is known to have immunomodulatory and anti-inflammatory properties, which are thought to help reduce the weight loss associated with cachexia. Preliminary studies of thalidomide have demonstrated encouraging results.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 254 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Hong Kong 1 <1%
Ireland 1 <1%
Canada 1 <1%
United Kingdom 1 <1%
Unknown 248 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 16%
Researcher 28 11%
Student > Bachelor 25 10%
Student > Ph. D. Student 22 9%
Student > Postgraduate 16 6%
Other 50 20%
Unknown 72 28%
Readers by discipline Count As %
Medicine and Dentistry 91 36%
Nursing and Health Professions 28 11%
Psychology 15 6%
Biochemistry, Genetics and Molecular Biology 9 4%
Social Sciences 7 3%
Other 23 9%
Unknown 81 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2020.
All research outputs
#7,188,639
of 25,386,440 outputs
Outputs from Cochrane database of systematic reviews
#8,734
of 12,869 outputs
Outputs of similar age
#45,995
of 170,097 outputs
Outputs of similar age from Cochrane database of systematic reviews
#120
of 182 outputs
Altmetric has tracked 25,386,440 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 12,869 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.2. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,097 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 182 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.